Read + Share
Lee J, Park S, Jung HA, Lee SH, et al. A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination
therapy in recurrent or metastatic salivary gland carcinomas. Cancer 2023;129:2966-2974.
PMID: 37246414
|
 |
|
Lee J, Park S, Jung HA, Lee SH, et al. A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination
therapy in recurrent or metastatic salivary gland carcinomas. Cancer 2023;129:2966-2974.
PMID: 37246414
|
|
|
|